Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M48P3 pediatric TBE vaccine schedule comparison study
2004-003616-37Phase 4Completed
- Sponsor
- Chiron Behring Vaccines
- Start
- Dec 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tick-borne encephalitis vaccine (inactivated) in tick-borne encephalitis (TBE) (2 arms), sponsored by Chiron Behring Vaccines. Primary endpoint: Body temperature after first vaccination. Started Dec 2004; status: completed.
02
Drugs
tick-borne encephalitis vaccine (inactivated)
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2004-003616-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003616-37.